MYCN and cancer: Furthermore, TBX2 acts as a neuroblastoma core regulatory circuitry component that promotes MYCN/FOXM1-mediated reactivation of DREAM targets (Decaesteker et al., 2018), while CLOCK genes are closely associated with cancer development, particularly in endocrine tissues (Angelousi et al., 2019).